Dr. Karakikes's current research focus is the generation of isogenic induced pluripotent stem cells (iPSCs) using genome-editing technologies to unravel the pathogenesis of familial cardiomyopathies.

Dr. Markman’s research interests include the relationship between language and thought; early word learning; categorization and induction; theory of mind and pragmatics; implicit theories and conceptual change.

Understanding the biology of pre-malignant stem cell mutations and how they contribute to the development of cancer and other age-related diseases is the current focus of work in Dr. Jaiswal's lab.

Dr. Druckmann's lab is interested in elucidating the relationship between behavior and the underlying neuronal circuit structure and neural population dynamics.

Dr. Mahajan's laboratory's focus is the development of personalized medicine for eye diseases through translation of our discoveries in proteomics, genomics, and phenomics in humans, mice and tissue culture models.

Dr. van Rechem's long-term interest lies in understanding the impact chromatin modifiers have on disease development and progression so that more optimal therapeutic opportunities can be achieved.

Dr. Bintu's lab performs single-cell measurements of chromatin and gene regulation dynamics, and uses these data to develop predictive models of basic biological processes and improve mammalian cell engineering.

The O'Connell lab studies evolutionary innovations in physiology and behavior, from molecules to organisms to ecosystems.

Dr. Poldrack's lab uses the tools of cognitive neuroscience to understand how decision making, executive control, and learning and memory are implemented in the human brain.

Dr. Wu spearheads the oculoplastic research program at Stanford University and is developing cutting edge stem cell and regenerative medicine treatments for vision loss and other eye diseases.